Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2729582108;82109;82110 chr2:178564249;178564248;178564247chr2:179428976;179428975;179428974
N2AB2565477185;77186;77187 chr2:178564249;178564248;178564247chr2:179428976;179428975;179428974
N2A2472774404;74405;74406 chr2:178564249;178564248;178564247chr2:179428976;179428975;179428974
N2B1823054913;54914;54915 chr2:178564249;178564248;178564247chr2:179428976;179428975;179428974
Novex-11835555288;55289;55290 chr2:178564249;178564248;178564247chr2:179428976;179428975;179428974
Novex-21842255489;55490;55491 chr2:178564249;178564248;178564247chr2:179428976;179428975;179428974
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTT
  • RefSeq wild type template codon: GAA
  • Domain: Ig-140
  • Domain position: 18
  • Structural Position: 30
  • Q(SASA): 0.1169
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/V None None 0.9 D 0.474 0.484 0.660250038783 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.836 likely_pathogenic 0.8458 pathogenic -1.394 Destabilizing 0.983 D 0.725 prob.delet. None None None None N
L/C 0.8637 likely_pathogenic 0.8655 pathogenic -1.166 Destabilizing 1.0 D 0.73 prob.delet. None None None None N
L/D 0.999 likely_pathogenic 0.9992 pathogenic -2.351 Highly Destabilizing 0.999 D 0.862 deleterious None None None None N
L/E 0.993 likely_pathogenic 0.9941 pathogenic -2.111 Highly Destabilizing 0.999 D 0.866 deleterious None None None None N
L/F 0.4204 ambiguous 0.3921 ambiguous -1.03 Destabilizing 0.997 D 0.729 prob.delet. D 0.535502417 None None N
L/G 0.9843 likely_pathogenic 0.986 pathogenic -1.811 Destabilizing 0.999 D 0.867 deleterious None None None None N
L/H 0.983 likely_pathogenic 0.985 pathogenic -2.074 Highly Destabilizing 1.0 D 0.836 deleterious D 0.623113421 None None N
L/I 0.1052 likely_benign 0.1063 benign -0.147 Destabilizing 0.198 N 0.279 neutral N 0.503820307 None None N
L/K 0.9897 likely_pathogenic 0.9916 pathogenic -1.327 Destabilizing 0.999 D 0.857 deleterious None None None None N
L/M 0.1885 likely_benign 0.1865 benign -0.549 Destabilizing 0.998 D 0.667 neutral None None None None N
L/N 0.9951 likely_pathogenic 0.9962 pathogenic -1.98 Destabilizing 0.999 D 0.861 deleterious None None None None N
L/P 0.9896 likely_pathogenic 0.9896 pathogenic -0.555 Destabilizing 0.999 D 0.863 deleterious D 0.623113421 None None N
L/Q 0.9757 likely_pathogenic 0.9785 pathogenic -1.562 Destabilizing 0.999 D 0.856 deleterious None None None None N
L/R 0.9793 likely_pathogenic 0.9814 pathogenic -1.793 Destabilizing 0.999 D 0.845 deleterious D 0.623113421 None None N
L/S 0.9806 likely_pathogenic 0.9828 pathogenic -2.23 Highly Destabilizing 0.999 D 0.845 deleterious None None None None N
L/T 0.9073 likely_pathogenic 0.9224 pathogenic -1.854 Destabilizing 0.998 D 0.791 deleterious None None None None N
L/V 0.1474 likely_benign 0.1532 benign -0.555 Destabilizing 0.9 D 0.474 neutral D 0.566617048 None None N
L/W 0.9113 likely_pathogenic 0.9035 pathogenic -1.379 Destabilizing 1.0 D 0.806 deleterious None None None None N
L/Y 0.9439 likely_pathogenic 0.9459 pathogenic -1.146 Destabilizing 0.999 D 0.745 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.